Decarboxylase inhibitor

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
1. Stride length is highly relevant to mobility and is sensitive to the effects of levodopa in Parkinsonism. Its selection as the… (More)
Is this relevant?
1989
1989
We evaluated the effect of administration of L-dopa, alone or in combination with a peripheral decarboxylase inhibitor, on plasma… (More)
Is this relevant?
1988
1988
In an open study 25 depressed patients were treated with L-5-hydroxytryptophan (L-5-HTP) either alone or in combination with a… (More)
Is this relevant?
1983
1983
The gastric anti-ulcer activity of a specific histidine decarboxylase inhibitor naringenin, the aglycone of naringin, a naturally… (More)
Is this relevant?
1983
1983
The effects of the glutamic acid decarboxylase inhibitor 3-mercaptopropionic acid (MPA) on the concentration of GABA in the mouse… (More)
Is this relevant?
1981
1981
The gastric anti-ulcer activity of (+)-cyanidanol-3, a specific histidine decarboxylase inhibitor was studied on various types of… (More)
Is this relevant?
1978
1978
The effect of orally administered histidine decarboxylase inhibitor on liver function tests and histological appearance as well… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
1977
1977
Three parkinsonian patients who were nonresponders to levodopa treatment did not improve when shifted to levodopa-decarboxylase… (More)
Is this relevant?
1976
1976
Twenty male rats were trained to press a bar on a fixed-ratio (FR 32) schedule of water reinforcement. The behavioral effects of… (More)
Is this relevant?
1972
1972
Clinical trials on the effect of l-DOPA and decarboxylase inhibitor, Ro 4-4602, in the long-term treatment of Parkinson's disease… (More)
  • table 2
  • table 3
  • table 4
  • table 6
  • table 7
Is this relevant?